Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Tenkasi (previously Orbactiv)

Tenkasi 1 200 mg powder for concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 21

HOS-131365 · Präparat HOS-097053

Table 2: Frequency of adverse reactions by system organ class System organ class Frequency Adverse Reactions Infections and infestations Common Cellulitis, abscess (limb and subcutaneous) Uncommon Osteomyelitis Blood and lymphatic system disorders Common Anaemia Uncommon Eosinophilia, thrombocytopenia Immune system disorders Uncommon Hypersensitivity (see sections 4.3 and 4.4), anaphylactic reaction Unknown Anaphylactic shock Metabolism and nutrition disorders Uncommon Hypoglycaemia, hyperuricaemia Nervous system disorders Common Headache, dizziness Rare Tremor* Cardiac disorders Common Tachycardia Respiratory, thoracic and mediastinal disorders Uncommon Bronchospasm, wheezing, dyspnoea* Rare Hypoxia* Gastrointestinal disorders Common Nausea, vomiting, diarrhoea, constipation Uncommon Abdominal pain* Hepatobiliary disorders Common Liver function test abnormal (Alanine aminotransferase increased, Aspartate aminotransferase increased) Uncommon Blood bilirubin increased Skin and subcutaneous tissue disorders Common Urticaria, rash, pruritus

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.